Torrance, CA, United States
Sato Pharmaceutical Inc. recalls
4 recalls recorded since 2018, most recently on 12 March 2026. 2 are listed as ongoing. Status and classification are as published by the FDA.
Recalls4
Ongoing (FDA)2
Terminated or completed2
Class I (FDA)0
Ongoing Class III Food
- Recall started
- 12 March 2026
- Reason
- Product does not meet label claim for Vitamin E.
- Distribution
- Product was distributed to two domestic consignees who further distribute nationwide.
- Initiated
- Voluntary: Firm initiated
- Recall number
- H-0892-2026
- Yunker(branded) Energy & Health Herbal Supplement with Vitamins; Manufactured by Sato Pharmaceuticals Co. Ltd.; 30ml container. Packed in single serving, 3 units/pack, and 10 units per pack. Single UPC: 49873-916-11 3pa
Ongoing Class II Drugs
- Recall started
- 19 December 2025
- Reason
- Failed Disintegration Specifications: above the time expected.
- Distribution
- CA and HI
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0298-2026
- INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01
Terminated Class III Drugs
- Recall started
- 1 October 2019
- Terminated
- 18 August 2020
- Reason
- Subpotent Drug
- Distribution
- Nationwide within the United States, Guam and Saipan
- Initiated
- Voluntary: Firm initiated
- Recall numbers
- D-0323-2020, D-0325-2020, D-0324-2020, D-0322-2020
- Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 59779-534-01. UPC 050428345535
- Motion Sickness Strips (meclizine hydrochloride) 25 mg strips, 8-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 69842-288-01. UPC 5042849946
- WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (NDC 0363-1407-01, UPC 3 11917-18328 2 ) and b) 18-count boxes (NDC 0363-1407-02, UPC 3 11917-20318 8) Distributed by Sato Pharmaceutical INC. 2
- Zentrip (meclizine Hydrochloride), 25 mg strips, 8-strips per box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 49873-803-01. UPC 4987301603
Terminated Class III Drugs
- Recall started
- 1 October 2019
- Terminated
- 18 August 2020
- Reason
- Subpotent Drug: Formulated amount of sennosides component is less than labelled claim.
- Distribution
- Nationwide in the USA and Guam and Saipan, Northern Mariana Islands
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0303-2020
- Sankaijo BOTANICAL LAXATIVE (docusate sodium 8.33 mg and sennosides 1.36 mg) tablets, 150-count bottles, Manufactured by SATO PHARMACEUTICAL CO., LTD., 1-5-27 Motoakasaka Minato-KU Tokyo, Japan; SATO PHARMACEUTICAL, INC.
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.